Cite
HARVARD Citation
Chen, B. et al. (2020). Cetuximab versus bevacizumab maintenance following prior 8-cycle modified FOLFOXIRI plus cetuximab in Asian postmenopausal women with treatment-naive KRAS and BRAF wild-type metastatic colorectal cancer. Journal of international medical research. 48 (9), p. . [Online].